Milestone Pharmaceuticals MIST
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.02 | 105.07 | -0.15 | -17,257 | -17 | |
| 2025Q3 | 2.00 | 107.98 | -0.12 | -11,829 | -12 | |
| 2025Q2 | 1.94 | 104.29 | -0.20 | -12,531 | -13 | |
| 2025Q1 | 0.80 | 103.52 | -0.31 | -20,523 | -21 | |
| 2024Q4 | 2.36 | 107.90 | -0.19 | -12,348 | -12 | |
| 2024Q3 | 1.52 | 112.65 | -0.14 | -9,616 | -9 | |
| 2024Q2 | 1.32 | 113.99 | -0.13 | -9,662 | -9 | |
| 2024Q1 | 1.79 | 110.48 | -0.21 | -10,476 | -10 | |
| 2023Q4 | 1.67 | 108.20 | -0.32 | -13,800 | -14 | |
| 2023Q3 | 3.10 | 107.87 | -0.35 | -15,360 | -15 | |
| 2023Q2 | 2.85 | 107.99 | -0.37 | -16,436 | -16 | |
| 2023Q1 | 3.94 | 103.69 | -0.35 | -15,502 | -15 | |
| 2022Q4 | 3.96 | 104.42 | -0.31 | -13,759 | -13 | |
| 2022Q3 | 9.19 | 103.26 | -0.34 | -15,030 | -15 | |
| 2022Q2 | 6.15 | 100.95 | -0.40 | -16,806 | -17 | |
| 2022Q1 | 6.42 | 100.29 | -0.33 | -14,047 | -14 | |
| 2021Q4 | 6.55 | 100.20 | -0.40 | -16,918 | -17 | |
| 2021Q3 | 5.71 | 100.34 | -0.34 | -14,273 | -14 | |
| 2021Q2 | 5.50 | 92.47 | 0.02 | 712 | 1 | |
| 2021Q1 | 5.79 | 100.64 | -0.30 | -12,594 | -13 |